PAR 0.00% 25.5¢ paradigm biopharmaceuticals limited..

Where we at?, page-42

  1. 2,128 Posts.
    lightbulb Created with Sketch. 569
    39KP,

    what is this about FDA reverting in June and the FDA asking for a different pathway?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.